A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone
about
Current Status of Hybrid PET/MRI in Oncologic ImagingBone imaging in prostate cancer: the evolving roles of nuclear medicine and radiologyDiffusion imaging for therapy response assessment of brain tumorDiffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology.Neoplasia: the second decade.Diffusion MRI in early cancer therapeutic response assessment.Synergy between anti-CCL2 and docetaxel as determined by DW-MRI in a metastatic bone cancer modelA feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy.Voxel-by-voxel functional diffusion mapping for early evaluation of breast cancer treatmentDiffusion-weighted MRI for assessment of early cancer treatment response.Incremental value of magnetic resonance imaging in the advanced management of prostate cancer.Challenges in clinical prostate cancer: role of imaging.Predicting and monitoring cancer treatment response with diffusion-weighted MRI.Targeted therapies in renal cell cancer: recent developments in imagingAssessment of multiexponential diffusion features as MRI cancer therapy response metricsEarly treatment response in non-small cell lung cancer patients using diffusion-weighted imaging and functional diffusion maps--a feasibility studyApplications of molecular imaging.Prospective analysis of parametric response map-derived MRI biomarkers: identification of early and distinct glioma response patterns not predicted by standard radiographic assessment.Multi-site clinical evaluation of DW-MRI as a treatment response metric for breast cancer patients undergoing neoadjuvant chemotherapyIntegrated multimodal imaging of dynamic bone-tumor alterations associated with metastatic prostate cancer.Differential microstructure and physiology of brain and bone metastases in a rat breast cancer model by diffusion and dynamic contrast enhanced MRI.Bony metastases: assessing response to therapy with whole-body diffusion MRI.Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival.Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma.The parametric response map is an imaging biomarker for early cancer treatment outcome.Parametric response mapping of CT images provides early detection of local bone loss in a rat model of osteoporosis.Functional diffusion map as an imaging predictor of functional outcome in patients with primary intracerebral haemorrhage.Semiautomated Workflow for Clinically Streamlined Glioma Parametric Response MappingIntravoxel incoherent motion imaging of tumor microenvironment in locally advanced breast cancer.Serial MR diffusion to predict treatment response in high-grade pediatric brain tumors: a comparison of regional and voxel-based diffusion change metricsDiffusion-Weighted MRI as a Biomarker of Tumor Radiation Treatment Response Heterogeneity: A Comparative Study of Whole-Volume Histogram Analysis versus Voxel-Based Functional Diffusion Map AnalysisThe War on Cancer rages on.Diffusion-weighted MRI in abdominal oncology: clinical applications.The evolution of imaging in cancer: current state and future challenges.Tumor response assessments with diffusion and perfusion MRI.Geometric distortion correction in prostate diffusion-weighted MRI and its effect on quantitative apparent diffusion coefficient analysis.Imaging and evaluation of patients with high-risk prostate cancer.Non-Mono-Exponential Analysis of Diffusion-Weighted Imaging for Treatment Monitoring in Prostate Cancer Bone Metastases.Computer-aided Detection of Prostate Cancer with MRI: Technology and Applications.T(2)-weighted combined with diffusion-weighted images for evaluating prostatic transition zone tumors at 3 Tesla.
P2860
Q26825265-D977CECF-2371-4D6C-950E-97F7FF69214AQ28071705-45BC3BAE-7A12-416D-ABE7-9DCDD3585288Q30437277-B371C131-CB7E-42F3-BFC0-F1CE1A6711CCQ30483058-7FC2183B-DF3E-4B64-9B5A-77596DEB0D24Q30484000-C80CC9B3-D2FE-4972-B134-5E00FCC12F59Q31037179-5E1ADE04-B488-46B3-A1B9-75E4C9CDF671Q33414714-1E7F3563-028C-4455-B2E9-A402BB90486CQ33496147-28AFB01B-F414-4230-A532-3B76F93C6F94Q33584285-38F570F3-6A42-4BE0-9D0D-1E78D2F4045BQ33588005-739E5699-052E-4192-9BE0-BD6485ABF48AQ33772524-D205FC9E-A65F-4143-BA46-E31B89297ACDQ33945133-6BEE8546-1F2D-4EEA-A16F-B5BE004FDC15Q34052992-ED08A889-DE67-402D-A9B6-78EC6449E406Q34088696-56BFD1D5-6667-4DC2-8781-D719C49039DCQ34249651-DD1637DB-18D7-4B81-A465-D0B44F8C7DF6Q34302644-679A541C-31F0-4F72-B4C0-10226EF1A1F5Q35082412-3A909461-0057-45DB-9598-BEA3851B30DDQ35115962-8F6858AE-16FC-4075-AEF7-D66FBA991332Q35224703-C1862775-F992-44E2-8276-C74ED73B3036Q35598954-1E2D065A-5425-4A1B-9CD7-521BF2CF56C6Q35600833-F07D394F-243A-4B7C-BA94-A31FA3A93DC6Q35697593-01450ECB-535F-4A2A-844F-F515B427E892Q35698555-E88A9509-4AC9-4E7A-B622-060B28565F38Q35771783-7671E6EB-2514-4BF0-A158-EA1EEA600740Q35838767-E89A952F-97B2-4DA6-9220-A8EDDF8D5196Q36019924-BC7DBFEA-2568-40CA-9188-A316774C9EB8Q36294857-9375A7F4-6FE9-4373-B674-F814AB65A121Q36305786-02BFC88C-638E-4AD2-BFF5-0EB12C80EB89Q36407355-A3A073D9-4098-4153-B2C8-817030C97BE0Q37021537-C42E5BE3-0491-4B92-8470-6CAA66D39DD4Q37236015-70D34AC6-5C86-47B8-96C4-9BA3F79C7B99Q37478602-F1288DE8-784F-4D2F-BF8A-CEDAF7A0B8AAQ37689666-ECD634DD-0C3C-47AE-A936-B63B34030AC1Q37848518-D80FB4E5-AD6E-41E1-BED5-BBAB26ECEC8FQ37995577-0B403D66-B12A-47E5-83AB-056B4160884CQ38598175-3866D0B9-932D-49E4-AA59-8EE8F119735FQ38611187-32B302F6-B4F3-4659-8497-16BD10F18703Q38671355-34A39ABC-596C-4DFC-8F9B-199A5D2B894FQ38822172-379DDDAF-4A9A-44A5-B8BF-433853354D88Q39439451-C7C41F74-E86E-46B3-A3B2-188028395CFF
P2860
A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
A feasibility study evaluating ...... ic prostate cancer to the bone
@ast
A feasibility study evaluating ...... ic prostate cancer to the bone
@en
type
label
A feasibility study evaluating ...... ic prostate cancer to the bone
@ast
A feasibility study evaluating ...... ic prostate cancer to the bone
@en
prefLabel
A feasibility study evaluating ...... ic prostate cancer to the bone
@ast
A feasibility study evaluating ...... ic prostate cancer to the bone
@en
P2093
P2860
P356
P1433
P1476
A feasibility study evaluating ...... ic prostate cancer to the bone
@en
P2093
Alnawaz Rehemtulla
Brian D Ross
Charles R Meyer
Craig J Galban
Deborah A Bradley
Kuei C Lee
Maha Hussain
Thomas L Chenevert
Timothy D Johnson
P2860
P304
P356
10.1593/NEO.07954
P577
2007-12-01T00:00:00Z